Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study


Ozbalak M. M., Akay O. M., PEHLİVAN M., Yildiz B., UZAY A., Yigenoglu T. N., ...Daha Fazla

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, cilt.21, 2021 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 21
  • Basım Tarihi: 2021
  • Dergi Adı: CLINICAL LYMPHOMA MYELOMA & LEUKEMIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
  • Anahtar Kelimeler: relapsed and refractory, Hodgkin lymphoma, brentuximab vedotin, autologous stem cell transplantation, consolidation
  • İstanbul Üniversitesi Adresli: Evet